Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Nestle Pairs Nutrition Science Business With Pharma Firm Making Peanut Allergy Treatment

Sep 01 2020

• By Eileen Francis

Peanut allergy symbol and allergic risk concept or nut allergies as a medical icon with text embossed in a shelled ingredient as an allergen warning with 3D illustration elements.

Related Content

Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval

Aug 22 2016

Vital Proteins’ ‘Timely’ Immunity Product Launch Makes Time Right For Nestle Investment

Jun 10 2020

Private-Equity Investors Poised To Acquire Nestlé Skin Health, Promising US Expansion

May 16 2019

HBW Market News: VSI Focuses On First Offer, Nestle Invests In Consumer Health, Eosera Adds Products, Space, Staff

Oct 01 2019

Doubts Over DBV's Future As US FDA Rejects Peanut Allergy Patch

Aug 05 2020

Nestle Acquires IM HealthScience, Expands Medical Food Lineup In Latest US Consumer Move

Aug 18 2020

Related Companies

Nestle Health Science

Additional Topics

International Switzerland Europe United States South America Dietary Supplements M & A Advertising, Marketing & Sales Business Strategies Commercial Companies Deals FDA Ingredients Approvals Manufacturing Research & Development Consumer Dermatology

More from Deals

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window